Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP
Year: 2014
Type: article
Study design: Observational Study
Source: Blood
Institutions: The Ohio State University, University of Colorado Anschutz
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: atypical hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, terminal complement activation, complement biomarkers, C5a, membrane attack complex, thrombotic microangiopathy, ADAMTS13, eculizumab, plasma exchange, von Willebrand factor multimers, differential diagnosis, complement dysregulation
Open Access status: closed
Award: G956288503
OpenAlex ID: W2008458556
